Larx Apex LP

CIK 2038992 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Larx Apex LP.

Recent SEC filings

FiledFormAccession number
Sep 9, 2026D/A0002038992-26-000001
Oct 21, 2025D/A0002038992-25-000002
Sep 27, 2024D0002038992-24-000001